Improved hydrogel for tissue engineering
CA 2304093 A1 · Owner: Reprogenesis, Inc. · Inventors: Omstead, Daniel R.; Nelson, Gordon P.; Zhou, Tao
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides compositions for use in implanting into an animal comprising a biodegradable, biocompatible polymer which forms a hydrogel upon cross-linking. In a preferred mode, the polymer is cross-linked by multivalent ions; more preferably, a soluble salt of a multivalent ion and a sparingly soluble salt of a multivalent ion, these components being combined into a mixture which forms a partially hardened injectable hydrogel, the consistency , of the mixture being suitable for implanting the partially hardened hydrogel mixture into the animal, where the implanted partially hardened hydrogel , forms in situ a fully hardened hydrogel. Preferably the mixture also contains , a …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 18, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 18, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 18, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.